1. Home
  2. CYTK vs ACIW Comparison

CYTK vs ACIW Comparison

Compare CYTK & ACIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • ACIW
  • Stock Information
  • Founded
  • CYTK 1997
  • ACIW 1975
  • Country
  • CYTK United States
  • ACIW United States
  • Employees
  • CYTK N/A
  • ACIW N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • ACIW EDP Services
  • Sector
  • CYTK Health Care
  • ACIW Technology
  • Exchange
  • CYTK Nasdaq
  • ACIW Nasdaq
  • Market Cap
  • CYTK 5.0B
  • ACIW 5.6B
  • IPO Year
  • CYTK 2004
  • ACIW 1995
  • Fundamental
  • Price
  • CYTK $50.26
  • ACIW $50.56
  • Analyst Decision
  • CYTK Strong Buy
  • ACIW Buy
  • Analyst Count
  • CYTK 17
  • ACIW 6
  • Target Price
  • CYTK $82.00
  • ACIW $49.50
  • AVG Volume (30 Days)
  • CYTK 1.9M
  • ACIW 554.2K
  • Earning Date
  • CYTK 02-27-2025
  • ACIW 02-27-2025
  • Dividend Yield
  • CYTK N/A
  • ACIW N/A
  • EPS Growth
  • CYTK N/A
  • ACIW 160.38
  • EPS
  • CYTK N/A
  • ACIW 2.12
  • Revenue
  • CYTK $3,219,000.00
  • ACIW $1,617,813,000.00
  • Revenue This Year
  • CYTK N/A
  • ACIW $11.87
  • Revenue Next Year
  • CYTK $754.18
  • ACIW $6.95
  • P/E Ratio
  • CYTK N/A
  • ACIW $23.95
  • Revenue Growth
  • CYTK N/A
  • ACIW 13.31
  • 52 Week Low
  • CYTK $40.53
  • ACIW $30.61
  • 52 Week High
  • CYTK $81.36
  • ACIW $59.71
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 58.40
  • ACIW 37.12
  • Support Level
  • CYTK $45.05
  • ACIW $51.02
  • Resistance Level
  • CYTK $48.30
  • ACIW $53.00
  • Average True Range (ATR)
  • CYTK 2.80
  • ACIW 1.30
  • MACD
  • CYTK 0.61
  • ACIW -0.24
  • Stochastic Oscillator
  • CYTK 86.80
  • ACIW 1.46

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ACIW ACI Worldwide Inc.

ACI Worldwide Inc develops, markets, and installs a portfolio of software products focused on facilitating electronic payments. The firm also leverages its distribution network in the Americas; Europe, the Middle East, and Africa, or EMEA; and Asia-Pacific regions to sell software developed by third parties. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but majority of the revenue is generated in the United States and EMEA regions.

Share on Social Networks: